AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Pegasys marketing authorization granted by European Commission.(Brief Article)
2002 JUL 24 - (NewsRx.com & NewsRx.net) -- Roche announced that Pegasys (peginterferon alfa 2-a (40 kDa)), a new generation pegylated interferon for the treatment of hepatitis C, has been granted marketing authorization by the European Commission.
The decision was based on the unanimous positive opinion adopted by the Committee for Proprietary Medicinal Products on March 21, 2002.
This license allows millions of hepatitis C patients in the European Union to access a treatment with increased efficacy, even for those with the more difficult-to-treat forms of the disease.
"Today is a very important day for Roche and for Pegasys," said William M. Burns, head of the pharmaceutical division at Roche. "Many European physicians and patients have ...
- European Commission recognises Roche's pivotal trial in new PEGASYS label for...
- Press release article from: PR Newswire July 18, 2003 700+ words
...announced today that the European Commission has approved a new label for PEGASYS (peginterferon alfa 2...We are pleased that the European Commission has approved the label...patients who are prescribed PEGASYS and Copegus," said William...
- PEGASYS(R) Combination Therapy Approved for the Treatment of Hepatitis C and...
- Newspaper article from: PR Newswire Europe February 3, 2005 700+ words
...Both HIV and HCV The European Commission has approved PEGASYS(R) (peginterferon...The approval of PEGASYS combination therapy...follows the recent European Commission approval of PEGASYS for the treatment of...
- PEGASYS(R) Plus Ribavirin Combination Therapy Receives Positive Opinion in...
- Newspaper article from: PR Newswire Europe December 17, 2004 700+ words
...In APRICOT, treatment with PEGASYS plus ribavirin is associated...Multiple Indications for PEGASYS Today's indication closely follows the European Commission Decision in November, 2004 to approve PEGASYS for the treatment of patients...
- PEGASYS Immune System-Boosting Action Increases Chance of Remission in Chronic...
- Newspaper article from: PR Newswire Europe April 13, 2005 700+ words
...cases, patients treated with PEGASYS even achieved the ultimate...it is possible to achieve. PEGASYS recently became the first...pegylated interferon to receive European Commission approval for the treatment...Achieve Sustained Remission with PEGASYS Achieving a sustained response...
- FDA Grants Priority Review to PEGASYS(R) (peginterferon alfa-2a) And Ribavirin...
- Press release article from: PR Newswire July 15, 2002 700+ words
...PEGASYS. The PEG used in PEGASYS was licensed by Roche from...San Carlos, CA. In June, PEGASYS monotherapy and combination...marketing authorization by the European Commission, making it immediately available...Eastern European countries. PEGASYS has been approved for use...
- PEGASYS(R) Combination Therapy Eradicates Hepatitis C Virus in More Than 50% of...
- Press release article from: PR Newswire Europe November 29, 2004 700+ words
...3 patients treated with PEGASYS / COPEGUS combination therapy...risk of transmitting it." PEGASYS only approved pegylated interferon...received approval from the European Commission for all hepatitis C patients...candidates for treatment with PEGASYS and COPEGUS regardless of...
- PEGASYS combination therapy eradicates hepatitis C in 50% of "healthy" carriers.
- Newspaper article from: Obesity, Fitness & Wellness Week January 1, 2005 700+ words
...patients for treatment with PEGASYS (180 mcg/weekly) and COPEGUS...3 patients treated with PEGASYS / COPEGUS combination therapy...received approval from the European Commission for all hepatitis C patients...candidates for treatment with PEGASYS and COPEGUS regardless of...
- Inhale Reports that a Product Using Its PEGylation Technology Has Been Granted...
- Press release article from: Business Wire July 15, 2002 700+ words
...s response at week 12 to PEGASYS combination therapy. In June PEGASYS monotherapy and combination...marketing authorization by the European Commission, making it immediately...Eastern European countries. PEGASYS has been approved for use...
Source: HighBeam Research, Pegasys marketing authorization granted by European Commission.(Brief...